Blocking ZSCAN4 alone, or in conjunction with additional chemotherapeutic drugs, may offer a new approach for cancer treatment with a wider therapeutic window and means to restore cancer replicative aging in novel therapeutics. This evidence concerns the gene ZSCAN4 and cancer.